Health
Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies – News-Medical.Net
Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs,…
With the resurgence of the COVID-19 pandemic looming large in many parts of the world, the need for immunological tools such as monoclonal antibodies (mAbs) is more urgent, whether for diagnosis, treatment, or research on the virus. Now, a recent study published on the preprint server bioRxiv* in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.
The RBD in SARS-CoV-2 Immunology
The focus of most antibody developmen…
-
Noosa News17 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News16 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business15 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General19 hours agoFirst home buyers score early access to deposit scheme